SM
ARCT icon

Sabby Management’s Arcturus Therapeutics ARCT Stock Holding History

Sabby Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-443
Closed -$651K – 264
2016
Q4 		$651K Sell
443
-246
-36% -$3.68K 0.04% 175
2016
Q3 		$1.19M Buy
689
+51
+8% +$1.65K 0.04% 167
2016
Q2 		$2.01M Buy
638
+451
+241% +$14.2K 0.1% 109
2016
Q1 		$497K Buy
187
+116
+163% +$3.93K 0.02% 213
2015
Q4 		$314K Buy
+71
New +$3.2K 0.02% 268
2014
Q4 		– Sell
-83
Closed -$900 – 246
2014
Q3 		$900 Buy
+83
New +$10.8K 0.03% 156

Other funds holding ARCT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return